SILVER SPRING, Md., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) today announced the pricing of its initial public offering of 2,941,176 shares of common stock, consisting of 2,205,882 shares of Class A common stock and...
SILVER SPRING, Md. – September 28, 2020 – Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery,...
SILVER SPRING, Md., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients...
Expands Regenerative Medicine Product Portfolio and Leverages Proprietary Processing Platform to Protect and Preserve Native Bone Cells Silver Spring, Md. – June 29, 2020 – Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage, regenerative medicine...
Silver Spring, Md. – June 20, 2019 – Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced today it has signed an exclusive, multi-year distribution agreement with Medtronic for the U.S. orthopedic market. Per the...